Klinik für Urologie und Kinderurologie

Foto Team Urologie Studienzentrale

Studien zur überaktiven Blase und Harnblasenkarzinom

Dysport

A phase III, multicentre, randomised, double blind, parallel group, placebo controlled study to assess the efficacy and safety of one or more intradetrusor treatments of 600 or 800 units of Dysport® for the treatment of urinary incontinence in subjects with neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.

 

THE LEADERSHIP 301 TRIAL

Studie in Vorbereitung

The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the SHIP1 Pathway in Subjects with Interstitial Cystitis/Bladder Pain Syndrome Followed by 14 or 40-Week Extension Periods

 
 
 
 

Anmeldung und Information

Montag bis Freitag: 8 - 16 Uhr
T +49 (0)251- 83 49 94 9
T +49 (0)251- 83 47 44 6
F +49 (0)251 - 83 57 29 6